Clinical Trial Update: Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients

View source ↗

Summary

Clinical trial update on using combined [18F]FET PET and simultaneous MRI for follow-up in patients with recurrent glioblastoma that have been previously re-irr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Glioblastoma, Nervous System Neoplasms | Status: UNKNOWN